White label ELPA - ClinicalTrials.eu

Study Comparing Linvoseltamab to Elotuzumab, Pomalidomide, and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Not recruiting

3 1 1 1
Investigated diseases:
- Plasma cell myeloma refractory
Investigated drugs:
+1
Study on the Effects of Ruxolitinib Cream for Patients with Genital Vitiligo

Not recruiting

2 1 1
Investigated diseases:
- Vitiligo
Investigated drugs:
- Ruxolitinib
Study on Aspirin and Pantoprazole for Reducing Heart Attack Risk in Hospitalized Pneumonia Patients

Not recruiting

3 1 1
Investigated diseases:
Investigated drugs:
Study on the Effectiveness and Safety of Satralizumab for Patients with Type 1 Facioscapulohumeral Muscular Dystrophy

Not recruiting

2 1 1
Investigated diseases:
- Facioscapulohumeral muscular dystrophy
Investigated drugs:
- Satralizumab
Study of Retatrutide (LY3437943) for Patients with Obesity or Overweight and Knee Osteoarthritis

Not recruiting

3 1
Investigated diseases:
- Osteoarthritis
Investigated drugs:
- Ly3437943 Sodium
Study on the Effects of Budesonide, Glycopyrronium, and Formoterol on Exercise in Patients with Chronic Obstructive Pulmonary Disease (COPD)

Not recruiting

3 1 1
Investigated diseases:
- Chronic obstructive pulmonary disease
Investigated drugs:
Study of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
Study on Cardiovascular Risk Changes After Stopping and Restarting Estradiol in Older Transgender Women on Long-term Hormone Therapy

Not recruiting

3 1 1 1
Investigated drugs:
- Estradiol
- Estradiol Valerate
Study on the Effectiveness of Albaconazole and Fluconazole for Treating Acute Vaginal Yeast Infections in Women

Not recruiting

2 1 1
Investigated diseases:
- Vulvovaginal candidiasis
Investigated drugs:
Study of mRNA-4157 and Pembrolizumab for Patients with High-Risk Stage II-IV Melanoma

Not recruiting

3 1 1
Investigated diseases:
- Malignant melanoma
Investigated drugs:
- Pembrolizumab
- Mrna-4157
+4

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies